ANLL
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| CAR-pNK Cell Immunotherapy for Relapsed/Refractory CD33+ AML (NCT02944162) | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 2016-10-01 |
| Myeloablative Allogeneic Stem Cell Transplantation Using a Naive T-Cell Depleted Peripheral Blood Stem Cell Graft (NCT00814983) | Duke University | 2007-07-01 |
Track ANLL automatically
Every clearance here is in the API, with alerts when new ones post.